Recommendations for the management of hemophagocytic lymphohistiocytosis in adults

P La Rosée, AC Horne, M Hines… - Blood, The Journal …, 2019 - ashpublications.org
Hemophagocytic lymphohistiocytosis (HLH) is a severe hyperinflammatory syndrome
induced by aberrantly activated macrophages and cytotoxic T cells. The primary (genetic) …

Consensus-based guidelines for the recognition, diagnosis, and management of hemophagocytic lymphohistiocytosis in critically ill children and adults

MR Hines, T von Bahr Greenwood, G Beutel… - Critical care …, 2022 - journals.lww.com
OBJECTIVE: Hemophagocytic lymphohistiocytosis is a hyperinflammatory syndrome that
often requires critical care support and remains difficult to diagnose. These guidelines are …

[HTML][HTML] Adult-Onset Still's Disease—A Complex Disease, a Challenging Treatment

LA Macovei, A Burlui, I Bratoiu, C Rezus… - International Journal of …, 2022 - mdpi.com
Adult-onset Still's disease (AOSD) is a systemic inflammatory disorder with an unknown
cause characterized by high-spiking fever, lymphadenopathy, hepatosplenomegaly …

Expert consensus on the treatment of patients with adult-onset still's disease with the goal of achieving an early and long-term remission

R Giacomelli, R Caporali, F Ciccia… - Autoimmunity …, 2023 - Elsevier
We performed a comprehensive systematic targeted literature review and used the Delphi
method to formulate expert consensus statements to guide the treatment of adult-onset Still's …

[HTML][HTML] Systematic review on the use of biologics in adult-onset still's disease

B Fautrel, J Patterson, C Bowe, M Arber… - Seminars in Arthritis and …, 2023 - Elsevier
This systematic review (SR) describes the efficacy and safety of biologic disease modifying
anti-rheumatic drugs (bDMARDs) for patients with adult-onset Still's disease (AOSD). Three …

Current and emerging biological therapy in adult-onset Still's disease

Y Ma, J Meng, J Jia, M Wang, J Teng, D Zhu… - …, 2021 - academic.oup.com
Adult-onset Still's disease (AOSD) is a rare, but characteristic non-familial, multi-genic
systemic auto-inflammatory disorder, characterized by high spiking fever, salmon-like …

[HTML][HTML] Adult-onset Still's disease biological treatment strategy may depend on the phenotypic dichotomy

F Vercruysse, T Barnetche, E Lazaro, E Shipley… - Arthritis research & …, 2019 - Springer
Abstract Objectives Adult-onset Still's disease (AOSD) phenotype appears to be
dichotomized in systemic or chronic articular forms. As biologicals and particularly …

Canakinumab for the treatment of adult-onset Still's disease

P Sfriso, S Bindoli, A Doria, E Feist… - Expert Review of …, 2020 - Taylor & Francis
ABSTRACT Introduction: Adult-onset Still's disease (AOSD) is a rare multisystem
autoinflammatory disorder of unknown etiology, with clinical and biological similarities with …

Treatment and mortality of hemophagocytic lymphohistiocytosis in adult critically ill patients: a systematic review with pooled analysis

C Knaak, FS Schuster, P Nyvlt, C Spies… - Critical care …, 2020 - journals.lww.com
Objectives: Hemophagocytic lymphohistiocytosis is a cytokine release syndrome caused by
uncontrolled immune activation resulting in multiple organ failure and death. In this …

Management of adult-onset Still's disease: evidence-and consensus-based recommendations by experts

HL Leavis, PLA van Daele, C Mulders-Manders… - …, 2024 - academic.oup.com
Abstract Objectives Adult-onset Still's disease (AOSD) is a rare condition characterized by
fevers, rash, and arthralgia/arthritis; most doctors treating AOSD in the Netherlands treat< 5 …